Board of Directors
Stephen J. Gatto
Chairman & CEOPrior Chairman and Chief Executive Officer of Myriant Corporation and Chief Executive Officer of BC International Corp., Mr. Gatto has served on numerous presidential, congressional and US DOE/DOA committees and was appointed by the Clinton and Bush administrations, respectively, to the Biomass Research & Development Technical Advisory Committee.
Brian Fox
Brian Fox, CEO of Junonia Capital, has an established track record of creating and building health care companies through industry expertise and access to capital. He is a founder and Executive Chairman of Millennium Healthcare, the largest independent primary care practice in Florida. In 2014, through a founding investment, Mr. Fox helped create Community Based Care Integrated Health, a care coordination service provider.
Charlotte Hubbert
Dr. Charlotte Hubbert is Managing Director and Chief Investment Officer with the Autism Impact Fund where she leads the Life Sciences practice. Charlotte was previously Partner and head of Gates Foundation Venture Capital, a $500mm initiative at the Bill and Melinda Gates Foundation Strategic Investment Fund where she oversaw investing in innovative technologies that supported the foundation’s programs in global health and agriculture. Notably she led investments and served on the board of directors of Synlogic (Nasdaq: SYBX), Sera Prognostics, Lodo Therapeutics, Agtech Accelerator, Vedanta, and Vir Biotechnology (Nasdaq: VIR). Charlotte currently serves on the BODs of Entrinsic Health and Galileo Biosystems. Prior to joining the foundation, Charlotte was a vice president at H.I.G. BioVentures, investing broadly in healthcare. Charlotte began her career in early stage biotech, investing at Accelerator Corporation, where she was part of the founding team and oversaw management of five companies: Oncofactor, Groove Biopharma, Acylin Therapeutics, Xori, and Pharmselex. Charlotte earned a B.S. in microbiology from the University of Washington and a Ph.D. in pharmacology and cancer biology from Duke University for which she received the prestigious Harold Weintraub Award. She did her post-doctoral work in stem cells and regenerative medicine at the Institute for Stem Cells and Regenerative Medicine at the UW. Charlotte is a member of the Kauffman Society of Fellows (Class 14) and serves on the BOD of Life Science Washington, and the steering committees of the Fred Hutch Cancer Institute’s Evergreen Fund, UW Innovation Roundtable and Columbia University Lab-to-Market initiative. Charlotte has been honored as a Fierce Woman in Biopharma 2016 by FiercePharma, and as a leading Woman in Life Sciences 2016 by Life Science Washington.
Daniel B. Dennison, PhD
Ph.D. in food science and 25 years senior leadership roles at The Coca-Cola Company, including Vice President and Director of Research and Development, Vice President and Director of Scientific Affairs. Global thought leader in food safety, member of American Association of the Advancement of Science and the Institute of Food Technologies and founding member of the Centers for Disease Control Foundation.
Dennis Crowley
Dennis Crowley is senior vice president, Business Development & Licensing. Crowley joined Baxter in 2017 from Acelity L.P., where he served as senior vice president, Strategy and Business Development. Previously, he worked at Medtronic plc (and before that, Covidien plc) in roles of increasing responsibility between 2005 and 2015, most recently as vice president, Corporate Development. Crowley began his professional career with Tyco Healthcare in 1993 and served in various strategic, business development and operational roles during his 12-year tenure. Crowley received his bachelor’s degree in economics from Harvard College.
Gerard Hoetmer
Former Chief Executive Officer (CEO) for CSM. Former SVP Global Supply Chain Unilever
Michael Warren, PhD
Mike Warren founded AMJ in 1977, and has been its President since. A native of New York, Mike went to Gainesville to teach Electrical Engineering at UF in 1974 after completing his Ph.D. at MIT. After leaving UF in 1980, he co-founded an engineering consulting business which he sold in 1983 to devote full time attention to real estate development, construction and property management. Under his leadership, AMJ has grown into one of the premier commercial developers in the Gainesville area. In addition to serving on the board of numerous community associations, Mike has been a director of Gainesville State Bank (1972 – 1997) and Florida Citizens Bank (1998 – present).
Robert K. Coughlin
As President and CEO of the Massachusetts Biotechnology Council, Bob’s mission is to advance Massachusetts’ leadership in the life sciences to grow the industry, add value to the healthcare system and improve patient lives. Over the last decade, Bob has truly become a champion for patients by ensuring innovative companies have the best environment possible to research, develop, and commercialize breakthrough therapies and cures for people around the world who need and deserve them. Bob has spent his career in both the public and private sectors. Before joining MassBio, he served as the Undersecretary of Economic Development within Governor Deval Patrick’s administration, where he prioritized both healthcare and economic development issues and was a strong advocate for the life sciences industry in Massachusetts. Prior to that, he was elected as State Representative to the 11th Norfolk district for three terms. Bob has also held senior executive positions in the environmental services, capital management and venture capital industries.
Board Advisors
Bernard Kinane, MD
Board AdvisorChief of Pediatric Pulmonary and Sleep Medicine, Associate Chief for Education, Director of Pulmonary Genetics Program, and Director of Pulmonary Function and Pediatric Cardiopulmonary Exercise Laboratory as Mass General for Children. Dr. Kinane is a graduate of the University of Dublin with an MB. He went on to complete his Pediatric Residencies in Dublin and at the University of Texas South Western Medical School. He was appointed Chief of Pediatric Pulmonary at Massachusetts General Hospital in 2000 and now holds several leadership positions including Associate Chief for Education and Director of the Pediatric Sleep Program. Dr. Kinane provides innovative clinical care to patients with a variety of pulmonary conditions and is seen as an international expert on the genetic basis and treatment of interstitial lung diseases, lung developmental abnormalities, and the regulation of breathing.
Luba Greenwood, JD
Board AdvisorLuba is a veteran biotech and tech investor and company builder, having recently served as an executive at Google Life Sciences (Verily) and as Vice President of Global Business Development and Mergers & Acquisitions at Roche, where she also established and led the East Coast Innovation Hub. She serves as a Senior Advisor to the CEO of the Dana-Farber Cancer Institute, lectures at Harvard University in the School of Engineering and Applied Sciences, and advises the Wyss Center for Bio and Neuroengineering. Luba serves on numerous boards, including the Massachusetts Biotechnology Council (MassBio), Brooklyn ImmunoTherapeutics, and LUCA Biologics, is a Thought Leader for the New England Journal of Medicine (NEJM) Catalyst, and a Founder of the Pharma Digital Health Roundtable. Luba began her career as a litigator at a leading national law firm, Wilmer Cutler Pickering Hale and Dorr. She is a recipient of several awards and honors for her work in the community, including the Science Club for Girls Catalyst Award for her commitment to advocating for women in science and technology, and has served as a non-profit board member of Longwood Symphony Orchestra and executive coach for MassNextGen.
William (Pepper) Denman, MBChB, FRCA
Board AdvisorDr. Denman is a trusted advisor in the pharmaceutical space. He began his career at Tyco Healthcare and went on to serve as Chief Medical Officer and VP for Medical Affairs at Covidien followed by Chief Medical Officer at GE Healthcare. Using his vast industry knowledge, Dr. Denman formed Denman Associates, an advisory company dedicated to supporting start-up and early-stage ventures in the medical devise, diagnostic, and pharmaceutical space. He currently serves as Chief Medical Officer and co-founder of Scilogica, a diagnostic sensing company focused in the ICU space, as well as continuing to practice at Massachusetts General Hospital